(ACC),theAmericanHeartAssociation(AHA),
theEuropeanHeartRhythmAssociation
(EHRA),theCanadianHeartRhythmSociety
(CHRS),andtheInternationalSocietyforAdult
CongenitalHeartDisease(ISACHD).Heart
Rhythm.2014;11(10):e102–e165.
45.PlacidiS,etal.Miniaturizedimplantableloop
recorderinsmallpatients:aneffectiveapproach
totheevaluationofsubjectsatriskofsudden
death.PacingClinElectrophysiol.
2016;39(7):669–674.
46.AvariSilvaJN,etal.Implantablelooprecorder
monitoringforrefiningmanagementofchildren
withinheritedarrhythmiasyndromes.JAm
HeartAssoc.2016;5(6).
47.KoJK,etal.Supraventriculartachycardia
mechanismsandtheiragedistributionin
pediatricpatients.AmJCardiol.
1992;69(12):1028–1032.
48.WalshEP.Interventionalelectrophysiologyin
patientswithcongenitalheartdisease.
Circulation.2007;115(25):3224–3234.
49.OlenMM,etal.Wolff-Parkinson-White
syndrome:astepwisedeteriorationtosudden
death.Circulation.2016;133(1):105–106.
50.KleinGJ,etal.Ventricularfibrillationinthe
Wolff-Parkinson-Whitesyndrome.NEnglJ
Med.1979;301(20):1080–1085.
51.TimmermansC,etal.Idiopathicleftbundlebranchblock-shapedventriculartachycardia
mayoriginateabovethepulmonaryvalve.
Circulation.2003;108(16):1960–1967.
52.MungerTM,etal.Apopulationstudyofthe
naturalhistoryofWolff-Parkinson-White
syndromeinOlmstedCounty,Minnesota,19531989.Circulation.1993;87(3):866–873.
53.SantinelliV,etal.Thenaturalhistoryof
asymptomaticventricularpre-excitationalongtermprospectivefollow-upstudyof184
asymptomaticchildren.JAmCollCardiol.
2009;53(3):275–280.
54.SarubbiB,etal.Asymptomaticventricularpreexcitationinchildrenandadolescents:a15year
followupstudy.Heart.2003;89(2):215–217.
55.DubinAM,etal.Useofelectrophysiologic
testingtoassessriskinchildrenwithWolffParkinson-Whitesyndrome.CardiolYoung.
2002;12(3):248–252.
56.Pediatric,etal.PACES/HRSexpertconsensus
statementonthemanagementofthe
asymptomaticyoungpatientwithaWolffParkinson-White(WPW,ventricular
preexcitation)electrocardiographicpattern:
developedinpartnershipbetweenthePediatric
andCongenitalElectrophysiologySociety
(PACES)andtheHeartRhythmSociety(HRS).
EndorsedbythegoverningbodiesofPACES,
HRS,theAmericanCollegeofCardiology
Foundation(ACCF),theAmericanHeart
Association(AHA),theAmericanAcademyof
Pediatrics(AAP),andtheCanadianHeart
RhythmSociety(CHRS).HeartRhythm.
2012;9(6):1006–1024.
57.WackelP,etal.RiskstratificationinWolffParkinson-Whitesyndrome:thecorrelation
betweennoninvasiveandinvasivetestingin
pediatricpatients.PacingClinElectrophysiol.
2012;35(12):1451–1457.
58.SparDS,etal.Relationoftheutilityofexercise
testingforriskassessmentinpediatricpatients
withventricularpreexcitationtopathway
location.AmJCardiol.2012;109(7):1011–1014.
59.BrombergBI,etal.Impactofclinicalhistoryand
electrophysiologiccharacterizationofaccessory
pathwaysonmanagementstrategiestoreduce
suddendeathamongchildrenwithWolffParkinson-Whitesyndrome.JAmCollCardiol.
1996;27(3):690–695.
60.SharmaAD,etal.Sensitivityandspecificityof
invasiveandnoninvasivetestingforriskof
suddendeathinWolff-Parkinson-White